慢性阻塞性肺疾病患者血清 sICAM-1、炎性介质的检测及临床意义

牟涌, 蒋春彦

牟涌, 蒋春彦. 慢性阻塞性肺疾病患者血清 sICAM-1、炎性介质的检测及临床意义[J]. 实用临床医药杂志, 2014, (15): 28-31. DOI: 10.7619/jcmp.201415009
引用本文: 牟涌, 蒋春彦. 慢性阻塞性肺疾病患者血清 sICAM-1、炎性介质的检测及临床意义[J]. 实用临床医药杂志, 2014, (15): 28-31. DOI: 10.7619/jcmp.201415009
MOU Yong, JIANG Chunyan. The clinical significance of detection serum sICAM-1, inflammatory mediators levels of patients with chronic obstructive pulmonary disease[J]. Journal of Clinical Medicine in Practice, 2014, (15): 28-31. DOI: 10.7619/jcmp.201415009
Citation: MOU Yong, JIANG Chunyan. The clinical significance of detection serum sICAM-1, inflammatory mediators levels of patients with chronic obstructive pulmonary disease[J]. Journal of Clinical Medicine in Practice, 2014, (15): 28-31. DOI: 10.7619/jcmp.201415009

慢性阻塞性肺疾病患者血清 sICAM-1、炎性介质的检测及临床意义

详细信息
  • 中图分类号: R441.8

The clinical significance of detection serum sICAM-1, inflammatory mediators levels of patients with chronic obstructive pulmonary disease

  • 摘要: 目的:观察和分析慢性阻塞性肺疾病(COPD)患者血清可溶性细胞间黏附分子-1(sICAM-1)、炎性因子检测的临床意义。方法选取 COPD 急性加重期(AECOPD)患者60例作为 AECOPD 组,根据治疗前是否合并呼吸衰竭将其分为合并呼衰组和未合并呼衰组2个亚组;选取同期经常规治疗临床症状缓解的 AECOPD 患者60例作为 COPD 稳定期组;选取同期体检结果健康者60例作为对照组。对3组研究对象的血清 sICAM-1、白细胞介素-10(IL-10)、白细胞介素-18(IL-18)水平进行检测和分析。结果 AECOPD 组患者的血清 sICAM-1和 IL-18水平显著高于 COPD 稳定期组(P <0.05);COPD 稳定期组患者的血清 sICAM-1和 IL-18水平显著高于对照组(P <0.05);AECOPD 组患者的血清 IL-10水平显著低于 COPD 稳定期组(P <0.05);COPD 稳定期组患者的血清 IL-10水平显著低于对照组(P <0.05);合并呼衰组患者的血清 sICAM-1和 IL-18水平显著高于未合并呼衰组(P <0.05);合并呼衰组患者的血清 IL-10水平显著低于未合并呼衰组(P <0.05);AECOPD 组患者的血清 IL-10水平与血清 sICAM-1水平呈负相关关系(r =-0.53,P <0.05),而 AECOPD 组患者的血清 IL-18水平与血清sICAM-1水平呈正相关关系(r =0.68,P <0.05)。结论血清 sICAM-1和 IL-18水平的上升以及血清 IL-10水平的下降可能与 AECOPD 的发生及其合并呼吸衰竭有相关性,血清 sICAM-1水平的上升可反映患者机体炎性反应的加剧状态。
    Abstract: Objective To observe and analyze clinical significance of detection of serum sol-uble intracellular adhesion molecule-1 (sICAM-1),inflammatory mediators levels for the patients with chronic obstructive pulmonary disease (COPD).Methods 60 patients with acute exacerbated COPD were selected as the AECOPD group and divided into complicated with respiratory failure group and the without complicated respiratory failure group according to whether the patients had been complicated with respiratory failure before the treatment;60 patients with AECOPD whose clinical symptoms were relieved after the routine treatment during the same period were selected as the COPD stable phase group;60 patients with healthy examination results during the same period were selected as the control group.The serum levels of sICAM-1,interleukin-10 (IL-10),inter-leukin-18 (IL-18)of the subjects in the three groups were detected and analyzed.Results The serum sICAM-1 and IL-18 levels of the patients in the AECOPD group were significantly higher than those of the COPD stable phase group (P <0.05)and the serum sICAM-1 and IL-18 levels of the patients in the COPD stable phase group were significantly higher than those of the control group (P <0.05);The serum IL-10 level of the patients in the AECOPD group was significantly lower than that of the COPD stable phase group (P <0.05)and the serum IL-10 level of the patients in the COPD stable phase group was significantly lower than that of the control group (P < 0 .0 5 );The serum sICAM-1 and IL-1 8 levels of the patients in the complicated with respiratory failure group were significantly higher than those of the without complicated respirato-ry failure group (P <0.05)and the serum IL-10 level of the patients in the complicated with res-piratory failure group was significantly lower thanthat of the without complicated respiratory fail-ure group (P <0.05);In the AECOPD group,the serum IL-10 level was negative related with the serum sICAM-1 level of (r =-0.53,P <0.05),while the serum IL-18 level was positively related with the serum sICAM-1 level (r =0.68,P <0.05).Conclusion The increased serum sICAM-1 and IL-18 levels and the decreased serum IL-10 level may be associated with the occur-rence of AECOPD and the complicated respiratory failure.The increasing of the serum sICAM-1 level can reflect the state of the inflammatory reaction of patients.
  • 期刊类型引用(13)

    1. 付中英,杨燕玲,苏月华,于晗澍,李曼,朱凤芹,常红. 过敏性紫癫患儿外周血单个核细胞中ASC mRNA和NLRP3 mRNA表达水平及其与并发肾炎的关系. 中国妇幼健康研究. 2024(11): 20-31 . 百度学术
    2. 刘阳,郝佳,卑雪,赵志佳,李阳. 过敏性紫癜患儿幽门螺杆菌感染及其对补体系统及炎症指标的影响. 中华医院感染学杂志. 2023(01): 138-141 . 百度学术
    3. 郭爱玲. 学龄前期HP阳性儿童的免疫功能及生长发育的特点. 哈尔滨医药. 2023(01): 33-35 . 百度学术
    4. 潘馨,刘佳奕,王艳,童敏,严方利,孙香娟. 幽门螺杆菌感染与儿童过敏性紫癜相关性的Meta分析. 医学信息. 2023(02): 92-98 . 百度学术
    5. 黄丽琴,江秀华. 微生态制剂结合抗Hp三联方案治疗Hp阳性腹型AP患儿的效果. 数理医药学杂志. 2022(06): 893-895 . 百度学术
    6. 孙文,黄雅玲,高健. 腹型过敏性紫癜患儿幽门螺杆菌感染与消化道出血的关系及相关因素探讨. 现代消化及介入诊疗. 2022(03): 355-358 . 百度学术
    7. 王彩芳,么鑫,蔡花,张菂,黄翠影,梁晓亮,陈瑞珊,海冬. 肺炎链球菌、肺炎支原体、柯萨奇病毒及EB病毒感染与儿童过敏性紫癜肾炎的相关性研究. 临床和实验医学杂志. 2022(19): 2099-2103 . 百度学术
    8. 刘力铭,张颖,赵子年,杨金玉,焦丽华,刘建丽,回广飞. 过敏性紫癜患儿呼吸道病毒感染特异性免疫球蛋白M检测及血清炎性因子变化. 临床军医杂志. 2021(07): 768-769 . 百度学术
    9. 王杨. 过敏性紫癜患儿血清中Cys C、TM与T淋巴细胞亚群的关系及易感因素分析. 中国医学创新. 2021(21): 10-14 . 百度学术
    10. 王士杰,胡方起,和平,余必信,邓芳. 黄芪颗粒联合氢化可的松琥珀酸钠治疗过敏性紫癜临床疗效与安全性探究. 中华中医药学刊. 2021(09): 169-172 . 百度学术
    11. 王婧,韩磊,张震,夏毓,姜烜星,汤兴萍. 儿童过敏性紫癜感染幽门螺杆菌的危险因素分析与治疗研究. 系统医学. 2021(16): 31-34 . 百度学术
    12. 李丹,张波,秦帅,刘宇. 微生态制剂结合抗幽门螺杆菌三联方案治疗儿童幽门螺杆菌阳性腹型过敏性紫癜的疗效分析. 中国现代医学杂志. 2021(19): 44-48 . 百度学术
    13. 郭志伟. 探究儿童过敏性紫癜临床用药的治疗效果. 中国继续医学教育. 2021(30): 156-159 . 百度学术

    其他类型引用(1)

计量
  • 文章访问数:  214
  • HTML全文浏览量:  45
  • PDF下载量:  1
  • 被引次数: 14
出版历程
  • 发布日期:  2014-09-10

目录

    /

    返回文章
    返回
    x 关闭 永久关闭